v3.25.3
Consolidated Cash Flow Statement - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Operating Activities        
Net income $ 1,539 $ 2,126    
Depreciation and amortization 616 564    
Asset impairments 0 114    
Stock-based compensation 115 110    
Deferred income taxes 204 (86)    
Net (gains) losses on asset and business dispositions 42 (474)    
Equity companies' earnings (in excess of) less than dividends paid (56) (93)    
Operating working capital (679) 154    
Postretirement benefits 17 10    
Other 7 (8)    
Cash Provided by Operations 1,805 2,417    
Investing Activities        
Capital spending (741) (512)    
Proceeds from asset and business dispositions 12 649    
Investments in time deposits (375) (456)    
Maturities of time deposits 416 428    
Other 38 (15)    
Cash (Used for) Provided by Investing (650) 94    
Financing Activities        
Cash dividends paid (1,242) (1,220)    
Change in short-term debt 414 2    
Repayments of Long-Term Debt (550) (554)    
Proceeds from exercise of stock options 40 128    
Repurchases of common stock (140) (752)    
Payments of Ordinary Dividends, Noncontrolling Interest (18) (19)    
Other (75) (65)    
Cash Used for Financing (1,571) (2,480)    
Effect of Exchange Rate Changes on Cash and Cash Equivalents 29 (13)    
Change in Cash and Cash Equivalents (387) 18    
Cash and cash equivalents from continuing operations - beginning of period 617 1,098 $ 1,010 $ 1,075
Cash and cash equivalents from discontinued operations - end of period(a) 17 13 11 18
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation $ 634 $ 1,111 $ 1,021 $ 1,093